Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

TraceLink to Present at the 36th Annual J.P. Morgan Healthcare Conference

TraceLink Inc.
Posted on: 02 Jan 18
TraceLink to Present at the 36th Annual J.P. Morgan Healthcare Conference

PR Newswire

NORTH READING, Mass., Jan. 2, 2018

NORTH READING, Mass., Jan. 2, 2018 /PRNewswire/ -- TraceLink Inc., the World's Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, today announced that Shabbir Dahod, president and CEO, will present at the 36th Annual J.P. Morgan Healthcare Conference on Wednesday, January 10 at 9:30 a.m. PST at the Westin St. Francis in San Francisco.

During his presentation, Dahod will discuss the global market opportunity for TraceLink's information-sharing network in the life sciences supply chain, and the role the Company's solutions play in the core digital strategy for pharmaceutical manufacturers, wholesale distributors, hospitals and pharmacies worldwide.

About TraceLink

TraceLink is the World's Largest Track and Trace Network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace. Leading businesses trust the TraceLink Life Sciences Cloud to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. A winner of numerous industry awards including Deloitte's Technology Fast 500 (ranked number 177 in 2017), the Amazon AWS Global Start-Up Challenge Grand Prize, and the Edison Award for Innovation, the Life Sciences Cloud is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost.

For more information on TraceLink and our solutions, visit or follow us on LinkedIn, Twitter and Facebook.

TraceLink is funded by Goldman Sachs, FirstMark Capital, Volition Capital and F-Prime Capital.

View original content:

SOURCE TraceLink Inc.

PR Newswire

Last updated on: 02/01/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.